Cargando…

Disease-specific haptoglobin-β chain N-glycosylation as biomarker to differentiate non-small cell lung cancer from benign lung diseases

Background: The association of pathological states with N-glycosylation of haptoglobin-β has attracted increasing attention. Materials & Methods: In the present study, disease-specific haptoglobin-β (DSHp-β) was separated from serum immunoinflammation-related protein complexes (IIRPCs) of 600 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tianjing, He, Chengyan, Zhang, Mo, Li, Xiaoou, Liu, Xiaofeng, Liu, Yujie, Zhang, Dan, Li, Zhili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843889/ https://www.ncbi.nlm.nih.gov/pubmed/31737099 http://dx.doi.org/10.7150/jca.32690

Ejemplares similares

Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases
por: Zhang, Dan, et al.
Publicado: (2016)

Simultaneous Quantification of Serum Nonesterified and Esterified Fatty Acids as Potential Biomarkers to Differentiate Benign Lung Diseases from Lung Cancer
por: Ren, Junling, et al.
Publicado: (2016)

Serum Unsaturated Free Fatty Acids: A Potential Biomarker Panel for Differentiating Benign Thyroid Diseases from Thyroid Cancer
por: Zhang, Yaping, et al.
Publicado: (2015)

Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer
por: Zhang, Yaping, et al.
Publicado: (2014)

Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreas
por: Guo, Yumei, et al.
Publicado: (2017)

Haptoglobin as a Biomarker
por: Naryzny, S. N., et al.
Publicado: (2021)

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016)

Haptoglobin polymorphism affects its N-glycosylation pattern in serum
por: Kohansal-Nodehi, M., et al.
Publicado: (2022)

Progress on haptoglobin and metabolic diseases
por: Wan, Bao-Nian, et al.
Publicado: (2021)

Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer
por: Yao, Lige, et al.
Publicado: (2023)

Monitoring changes of docosahexaenoic acid-containing lipids during the recovery process of traumatic brain injury in rat using mass spectrometry imaging
por: Guo, Shuai, et al.
Publicado: (2017)

Proteomic and genomic biomarkers for Non‐Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha‐1 antitrypsin
por: Najafi, Zahra, et al.
Publicado: (2020)

First bioelectronic immunoplatform for quantitative secretomic analysis of total and metastasis-driven glycosylated haptoglobin
por: Muñoz-San Martín, Cristina, et al.
Publicado: (2022)

The Role of Haptoglobin Genotypes in Chagas Disease
por: Mundaray Fernández, Ninomar, et al.
Publicado: (2014)

Serum Unsaturated Free Fatty Acids: A Potential Biomarker Panel for Early-Stage Detection of Colorectal Cancer
por: Zhang, Yaping, et al.
Publicado: (2016)

Pulmonary haptoglobin (pHp) is part of the surfactant system in the human lung
por: Abdullah, Mahdi, et al.
Publicado: (2012)

Differences between the Glycosylation Patterns of Haptoglobin Isolated from Skin Scales and Plasma of Psoriatic Patients
por: Maresca, Bernardetta, et al.
Publicado: (2012)

Social Disparities in Benign Lung Diseases
por: Espinosa, Jairo, et al.
Publicado: (2022)

Integrated analysis reveals lung fibrinogen gamma chain as a biomarker for chronic obstructive pulmonary disease
por: Zhang, Hai, et al.
Publicado: (2021)

Serum Surfactant Protein D and Haptoglobin as Potential Biomarkers for Inflammatory Airway Disease in Horses
por: Bullone, M., et al.
Publicado: (2015)

Elevated tumor markers in a benign lung disease
por: Chen, Quan, et al.
Publicado: (2021)

Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling
por: OKANO, TETSUYA, et al.
Publicado: (2016)

Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021)

Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage
por: Blackburn, Spiros L., et al.
Publicado: (2018)

Endothelial cell apoptosis correlates with low haptoglobin concentrations in diabetes
por: Dalan, Rinkoo, et al.
Publicado: (2017)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022)

Haptoglobin 1 allele predicts higher serum haptoglobin concentration and lower multiorgan failure risk in sickle cell disease
por: Ruiz, Maria A., et al.
Publicado: (2022)

Role of Haptoglobin in Health and Disease: A Focus on Diabetes
por: MacKellar, Mark, et al.
Publicado: (2016)

The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes
por: Somer, Shmuel, et al.
Publicado: (2020)

Effect of porcine respiratory coronavirus infection on lipopolysaccharide recognition proteins and haptoglobin levels in the lungs
por: Van Gucht, Steven, et al.
Publicado: (2006)

Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis
por: Yu, Rui, et al.
Publicado: (2023)

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
por: Li, Shumin, et al.
Publicado: (2020)

Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers
por: Fang, Kai, et al.
Publicado: (2022)

Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
por: Li, Liubing, et al.
Publicado: (2017)

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
por: Lu, Jianjun, et al.
Publicado: (2016)

Plasma Haptoglobin Concentrations Are Elevated in Patients with Coronary Artery Disease
por: Lee, Chin-Wei, et al.
Publicado: (2013)

Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients
por: Edwards, Olivia, et al.
Publicado: (2022)

Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform
por: Jeong, Seunghyup, et al.
Publicado: (2021)

Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease
por: Strandhave, Charlotte, et al.
Publicado: (2013)

Ultrasensitive haptoglobin biomarker detection based on amplified chemiluminescence of magnetite nanoparticles
por: Nirala, Narsingh R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ub2te1n3u3j9dpe17blp1ehpau